| Day Low 09:45 AM EDT | 43.69 | |
|---|---|---|
| Day High 09:30 AM EDT | 44.50 |
|
| Range | 0.81 | |
| Volume | 6.46 M | |
| 30-Day Avg. Vol. | 8.16 M |
|
| Difference | -20.77% | |
| Market Cap. | 58.85 B | |
| Change | -373.33 M | |
| Shares Out. | 1.33 B | |
| Percent Traded | 0.48% | |
| Revenue | 22.39 B | |
| Earnings | 4.61 B | |
| EPS (TTM) | 3.35 |
| 52-Wk Low 3/17/08 | 38.39 | |
|---|---|---|
| 52-Wk High 6/28/07 | 59.00 |
|
| Range | 20.61 | |
| Prev. Close 5/15/08 | 44.42 | |
| Today's Open | 44.50 | |
| Change | 0.18% | |
| Dividend (TTM) | 1.08 | |
| Div. Yield (TTM) | 2.54% |
|
| Beta | 0.56 | |
| P/E Ratio (TTM) | 13.18 | |
| P/E Ratio (Fwd.) | 12.00 |
Wyeth is wise in the ways of health care. The company operates in three segments, the largest being its Pharmaceuticals business, which sells antidepressant Effexor, arthritis drug Enbrel (with partner ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | 0.78 12/31/07 | 0.78 12/31/07 |
-0.008
Missed
|
| Last Quarter | 0.89 3/31/08 | 0.94 3/31/08 |
0.04
Beat
|
| Quarterly - 03/31/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 5.71 B | 22.40 B |
| Gross Profit | 4.39 B | 16.33 B |
| Operating Income | 1.59 B | 6.35 B |
| Net Income | 1.20 B | 4.62 B |
